{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:04:53Z","timestamp":1789409093554,"version":"build-2803163510"},"reference-count":15,"publisher":"Palacky University Olomouc","issue":"3","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub","Biomed. Pap-Olomouc","BIOMEDICAL PAPERS-OLOMOUC","BIOMED PAP"],"published-print":{"date-parts":[[2022,9,14]]},"DOI":"10.5507\/bp.2021.035","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T02:48:41Z","timestamp":1623034121000},"page":"322-327","source":"Crossref","is-referenced-by-count":4,"title":["Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker\/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic"],"prefix":"10.5507","volume":"166","author":[{"given":"Renata","family":"Aiglova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Taborsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lazarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludek","family":"Pavlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Danek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Precek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit","family":"Gloger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlastimil","family":"Cernicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Vicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Skala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3461","reference":[{"key":"ref0","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214363"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.08.187"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.762"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.617"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crvasa.2016.09.004"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.273.18.1450"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14284-5"},{"issue":"11","key":"ref9","first-page":"959","article-title":"Pharmacotherapy of chronic heart failure after the first decade of 21st century","volume":"57","author":"Spinar","year":"2011","journal-title":"Vnitrni lekarstvi"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.813"},{"issue":"7-8","key":"ref11","first-page":"646","article-title":"Heart Failure with Preserved Ejection Fraction","volume":"62","author":"Spinar","year":"2016","journal-title":"Vnit\u0159n\u00ed l\u00e9ka\u0159stv\u00ed"},{"issue":"11","key":"ref12","first-page":"966","article-title":"Pharmacotherapy following myocardial infarction","volume":"57","author":"Spinarova","year":"2011","journal-title":"Vnit\u0159n\u00ed l\u00e9ka\u0159stv\u00ed"},{"issue":"9","key":"ref13","first-page":"778","article-title":"FARIM-FARmakoterapie po Infarktu Myokardu (Post-Myocardial Infarction Pharmacotherapy Study)","volume":"57","author":"Spinar","year":"2011","journal-title":"Vnitrni lekarstvi"},{"issue":"5","key":"ref14","first-page":"202","article-title":"Sekund\u00e1rn\u00ed prevence po infarktu myokardu-re\u017eimov\u00e9 a farmakologick\u00e9 postupy","volume":"13","author":"Vitovec","year":"2011","journal-title":"Intern\u00ed medic\u00edna pro praxi"}],"container-title":["Biomedical Papers"],"original-title":[],"link":[{"URL":"http:\/\/biomed.papers.upol.cz\/doi\/10.5507\/bp.2021.035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:20:32Z","timestamp":1789406432000},"score":1,"resource":{"primary":{"URL":"http:\/\/biomed.papers.upol.cz\/doi\/10.5507\/bp.2021.035.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9,14]]}},"URL":"https:\/\/doi.org\/10.5507\/bp.2021.035","relation":{},"ISSN":["1213-8118","1804-7521"],"issn-type":[{"value":"1213-8118","type":"print"},{"value":"1804-7521","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}